ZYMEWORKS INC (ZYME) Forecast, Price Target & Analyst Ratings

NASDAQ:ZYME • US98985Y1082

Current stock price

26.32 USD
-1.03 (-3.77%)
At close:
26.32 USD
0 (0%)
After Hours:

Analyst forecast overview

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for ZYMEWORKS INC (ZYME).

Forecast Snapshot

Consensus Price Target

Price Target
$40.88
+ 55.31% Upside
→ Price target details

Next Earnings Forecast

Earnings Estimate
Release Date
May 6, 2026
Period
Q1 / 2026
EPS Estimate
-$0.26
Revenue Estimate
13.565M
→ Full earnings forecast details

ChartMill Buy Consensus

Rating
85.00%
Weighted Analyst Rating Score
→ Analyst Ratings details

Price Target Details & History

Consensus Price Target and Range

Mean target
$40.88
Upside
+ 55.31%
From current price of $26.32 to mean target of $40.88, Based on 20 analyst forecasts
Low
$31.31
Median
$40.80
High
$60.90

Price Target Revisions

1 Month
12.53%
3 Months
12.77%

Price Target Summary

20 Wall Street analysts provided a forecast for the next 12 months for ZYME. The average price target is 40.88 USD. This implies a price increase of 55.31% is expected in the next year compared to the current price of 26.32.
The average price target has been revised upward by 12.77% in the past 3 months.
→ Find peer stocks trading 30% below analyst price target

Analyst Ratings & History

Current Analyst Ratings

ZYME Current Analyst RatingZYME Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 2 4 6 8 10

Analyst Ratings History

ZYME Historical Analyst RatingsZYME Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 5 10 15

Analyst Ratings Consensus

ChartMill Buy Consensus
85.00%
ZYME was analyzed by 20 analysts. The buy percentage consensus is at 85. So analysts seem to be very confident about ZYME.
In the previous month the buy percentage consensus was at a similar level.
ZYME was analyzed by 20 analysts, which should be a sufficient number of analysts to have a meaningful average consensus rating.
→ Find peer stocks with a buy consensus above 85%

Recent Upgrades & Downgrades

DateFirmActionFrom → To
2026-03-09Evercore ISI GroupMaintains Outperform -> Outperform
2026-03-06HC Wainwright & Co.Maintains Buy -> Buy
2026-03-03Leerink PartnersMaintains Outperform -> Outperform
2026-03-03StifelMaintains Buy -> Buy
2025-12-17Truist SecuritiesInitiate Buy
2025-12-12Wells FargoUpgrade Equal-Weight -> Overweight
2025-12-03CitizensInitiate Market Outperform
2025-11-21B. Riley SecuritiesReiterate Buy -> Buy
2025-11-19StifelMaintains Buy -> Buy
2025-11-19Wells FargoMaintains Equal-Weight -> Equal-Weight
2025-11-18HC Wainwright & Co.Maintains Buy -> Buy
2025-11-07Wells FargoMaintains Equal-Weight -> Equal-Weight
2025-10-16JP MorganMaintains Overweight -> Overweight
2025-10-14HC Wainwright & Co.Upgrade Neutral -> Buy
2025-10-10B. Riley SecuritiesInitiate Buy
2025-08-11CitigroupMaintains Buy -> Buy
2025-07-03HC Wainwright & Co.Reiterate Neutral -> Neutral
2025-05-20TD SecuritiesInitiate Buy
2025-03-11LifeSci CapitalInitiate Outperform
2025-03-10HC Wainwright & Co.Maintains Neutral -> Neutral
2025-03-07CitigroupMaintains Buy -> Buy
2024-12-19Wells FargoMaintains Equal-Weight -> Equal-Weight
2024-12-16JP MorganUpgrade Neutral -> Overweight
2024-11-22HC Wainwright & Co.Reiterate Neutral -> Neutral
2024-11-07Leerink PartnersUpgrade Market Perform -> Outperform

Next Earnings Forecast Details

Next Earnings Details

Release Date
May 6, 2026
Period
Q1 / 2026
EPS Estimate
-$0.26
Revenue Estimate
13.565M
Revenue Q2Q
-49.96%
EPS Q2Q
13.68%
Number of Analysts
13

Next Earnings Revisions

Revenue (1 Month)
-50.04%
Revenue (3 Months)
-41.17%
EPS (1 Month)
-54.14%
EPS (3 Months)
-148.49%

Next Earnings Summary

ZYME is expected to report earnings on 5/6/2026. The consensus EPS estimate for the next earnings is -0.26 USD and the consensus revenue estimate is 13.56M USD.
The next earnings revenue estimate has been revised downward by 41.17% in the past 3 months. Downward revisions are a negative sign and indicate that analysts are more pessimistic about the next earnings compared to 3 months ago.
→ Find peers expecting at least 20% revenue growth next quarter

Full Analyst Estimates 2026 - 2033

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033
Revenue
YoY % growth
ZYME revenue by date.ZYME revenue by date.
76.012M
-81.57%		76.304M
0.38%		105.965M
38.87%		296.84M
180.13%		198.07M
-33.27%		226.89M
14.55%		332.62M
46.60%		436.01M
31.08%		556.03M
27.53%		706.64M
27.09%		675.8M
-4.36%
EBITDA
YoY % growth
ZYME ebitda by date.ZYME ebitda by date.
-127.889M
-192.88%		-111.139M
13.10%		-84.824M
23.68%		38.166M
144.99%		106.39M
178.76%		N/AN/AN/AN/AN/AN/A
EBIT
YoY % growth
ZYME ebit by date.ZYME ebit by date.
-138.053M
-205.79%		-119.823M
13.21%		-92.549M
22.76%		94.992M
202.64%		-17.23M
-118.14%		-8.041M
53.33%		41.848M
620.45%		86.521M
106.75%		144.1M
66.55%		224.43M
55.75%		224.42M
0.00%
Operating Margin
ZYME operating margin by date.ZYME operating margin by date.
-181.62%-157.03%-87.34%32.00%-8.70%-3.54%12.58%19.84%25.92%31.76%33.21%
EPS
YoY % growth
ZYME eps by date.ZYME eps by date.
-1.73
-189.64%		-1.39
19.65%		-1.08
22.30%		-0.29
72.72%		-0.56
-89.71%		0.25
144.25%		0.43
74.23%		0.85
98.22%		1.45
69.85%		2.24
54.19%		2.04
-8.66%

All data in USD

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26 Q1 / 27 Q2 / 27 Q3 / 27 Q4 / 27 Q1 / 28 Q2 / 28 Q3 / 28 Q4 / 28
EPS
Q2Q % growth		-0.26
13.68%		-0.38
-1,350.21%		0.83
419.62%		0.33
160.09%		-0.13
48.01%		0.24
163.50%		-0.10
-111.97%		-0.07
-119.75%		-0.21
-58.33%		-0.21
-186.08%		-0.19
-89.74%		-0.18
-176.56%
Revenue
Q2Q % growth		13.565M
-49.96%		26.841M
-44.91%		146.52M
430.60%		53.908M
2,043.46%		N/AN/AN/AN/AN/AN/AN/AN/A
EBITDA
Q2Q % growth		-44.576M
-93.68%		N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
EBIT
Q2Q % growth		-13.597M
46.91%		-32.932M
-4,786.05%		37.837M
271.13%		152.76M
445.99%		N/AN/AN/AN/AN/AN/AN/AN/A

All data in USD

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

ZYME Yearly Revenue VS EstimatesZYME Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 200M 400M 600M
ZYME Yearly EPS VS EstimatesZYME Yearly EPS VS EstimatesYearly EPS VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 0 2 -2 -4

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year
30.63%
EPS Next 5 Year
22.79%

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year
22.16%
Revenue Next 5 Year
28.50%

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year
N/A
EBIT Next 5 Year
N/A
→ Find peers expecting at least 20% CAGR revenue growth over the next 3 years

ZYMEWORKS INC / ZYME Forecast FAQ

What is the average price target for ZYMEWORKS INC (ZYME) stock?

20 analysts have analysed ZYME and the average price target is 40.88 USD. This implies a price increase of 55.31% is expected in the next year compared to the current price of 26.32.

When does ZYMEWORKS INC (ZYME) report earnings?

ZYMEWORKS INC (ZYME) will report earnings on 2026-05-06.

What are the consensus estimates for ZYME stock next earnings?

The consensus EPS estimate for the next earnings of ZYMEWORKS INC (ZYME) is -0.26 USD and the consensus revenue estimate is 13.56M USD.

How many analysts cover ZYMEWORKS INC (ZYME) stock?

The number of analysts covering ZYMEWORKS INC (ZYME) is 20.